Monographie - Asparaginase - Stabilis 4.0

Ultimele actualizari :
19/11/2024

Citostatic

Asparaginase

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

pdf

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Elspar	Mexic, SUA
Kidrolase	Arabia Saudita, Argentina, Bulgaria, Canada, Chilli, Columbia, Ecuador, Egipt, Israel, Maroc, Turcia
L Aspase	India
Laspar	Africa de Sud
Leunase	Australia, Japonia, Malaezia, Mexic
Paronal	Belgia, Italia, Olanda
Spectrila	Franta

Bibliografie

Injectabil

Bibliografie : Asparaginase

	tip	publicare
150	ziar	Aujoulat P, Coze C, Braguer D, Raybaud C. Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens. J Pharm Clin 1993 ; 12: 31-35.
1858	ziar	Stecher AL, Morgantetti de Deus P, Polikarpov I, Abrahao-Neto J. Stability of L-asparaginase: an enzyme used in leukemia treatment. Pharm Acta Helv 1999 ; 74: 1-9.
2148	ziar	Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum. Anal Biochem 2002 ; 309: 117-126.
3128	Laborator	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3243	poster	Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M. Stability of diluted L-asparaginase in normal saline solution. ECCO Congress Stockholm 2011
3686	Laborator	L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit Eusapharma 2013
4471	Laborator	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019

Mentions Légales